Stella Pharma: Announcements of individual stocks: Orphan drug designation application for recurrent malignant glioma and recurrent meningioma for Boro-Falan (10B) (SPM-011).

JPX · Aug 20 16:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.